✦ LIBER ✦

Phase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumours

✍ Scribed by Helen J. Mackay; Hal Hirte; Terrence Colgan; Al Covens; Katrina MacAlpine; Pamela Grenci; Lisa Wang; Jaqueline Mason; Pnu-An Pham; Ming-S. Tsao; James Pan; James Zwiebel; Amit M. Oza

Book ID: 116430343
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 328 KB
Volume: 46
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2010.02.047

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of imatinib mesylate in p

Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers

✍ Robert L. Coleman; Russell R. Broaddus; Diane C. Bodurka; Judith K. Wolf; Thomas 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Phase I trial of the proteasome inhibito

Phase I trial of the proteasome inhibitor bortezomib in combination with carboplatin in patients with platinum- and taxane-resistant ovarian cancer

✍ Pedro T. Ramirez; Charles N. Landen Jr.; Robert L. Coleman; Michael R. Milam; Ch 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 125 KB

The PACOVAR-trial: A phase I/II study of

The PACOVAR-trial: A phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer

✍ Michael Eichbaum; Christine Mayer; Regina Eickhoff; Esther Bischofs; Gerhard Geb 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 191 KB

Mutation and Protein Expression Biomarke

Mutation and Protein Expression Biomarkers Correlate with Response to AKT Inhibition in a Phase I Trial of the Oral Pan AKT Inhibitor GSK2141795 (GSK795) in Patients (pts) with Platinum Resistant Ovarian Cancer

✍ H. Gunqor; E. Stronach; E. Curry; A. Saleem; R. Agarwal; S. Blagden; S. Babar; G 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Long-term follow-up of a phase II trial

Long-term follow-up of a phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer in the Southwest Oncology Group

✍ D. S. Alberts; C. Jiang; P. Y. Liu; S. Wilczynski; M. Markman; M. L. Rothenberg 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Efficacy and safety of AEZS-108 (INN: Zo

Efficacy and safety of AEZS-108 (INN: Zoptarelin Doxorubicin Acetate) an LHRH agonist linked to doxorubicin in women with platinum refractory or resistant ovarian cancer expressing LHRH receptors: A multicenter Phase II trial of the ago-study group (AGO GYN 5)

✍ Emons, Günter; Gorchev, Grigor; Sehouli, Jalid; Wimberger, Pauline; Stähle, Anne 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 175 KB